Overview
- TrumpRx went live on February 6 listing more than 40 prescription medicines, including GLP‑1 weight‑loss drugs such as Ozempic and Wegovy.
- Users search the site to obtain coupons for participating pharmacies or are routed to manufacturers’ direct-purchase pages rather than buying through the portal itself.
- The White House touts steep introductory prices on select drugs — with examples such as $199 per month for Ozempic and Wegovy — while noting prices will rise after the first two months.
- The initiative is pitched primarily to uninsured or self‑pay patients, and the site cautions that insured consumers may pay less through their health plans or via generics.
- Officials say multiple drugmakers, including Pfizer, Eli Lilly, Novo Nordisk and Merck, are participating under agreements tied to lower prices, as experts question how many patients will realize true savings after earlier launch delays.